353 filings
ARS
2023 FY
BIOR
Biora Therapeutics Inc
24 Apr 24
Annual report to shareholders
4:11pm
DEFA14A
BIOR
Biora Therapeutics Inc
24 Apr 24
Additional proxy soliciting materials
4:06pm
DEF 14A
BIOR
Biora Therapeutics Inc
Definitive proxy
24 Apr 24
4:01pm
EFFECT
BIOR
Biora Therapeutics Inc
18 Apr 24
Notice of effectiveness
12:15am
PRE 14A
BIOR
Biora Therapeutics Inc
Preliminary proxy
12 Apr 24
4:30pm
SC 13D/A
iug8i06iutmsgot0paw3
2 Apr 24
BIORA THERAPEUTICS / Athyrium Opportunities 2020 ownership change
8:43pm
8-K
hw6r99
2 Apr 24
Entry into a Material Definitive Agreement
4:48pm
424B5
uw74zkmwr
2 Apr 24
Prospectus supplement for primary offering
4:46pm
424B5
e16cf9
2 Apr 24
Prospectus supplement for primary offering
4:44pm
424B5
0i5h4hf70c0xh4hhudvp
2 Apr 24
Prospectus supplement for primary offering
4:41pm
424B5
fb7f57g8upc378ze
2 Apr 24
Prospectus supplement for primary offering
4:40pm
424B5
cde3e
2 Apr 24
Prospectus supplement for primary offering
4:37pm
424B5
vsxmnyiy95ye0hr8
2 Apr 24
Prospectus supplement for primary offering
4:35pm
424B5
7f4ogihcbb
1 Apr 24
Prospectus supplement for primary offering
4:02pm
8-K
jywakl5d5r2u6
26 Mar 24
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
4:10pm
8-K
sla8za0l0qtx55pjzuf
11 Mar 24
Entry into a Material Definitive Agreement
8:11am
4
rmwh yqdd5neb
15 Feb 24
BIORA THERAPEUTICS / Eric dEsparbes ownership change
4:05pm
4
izor39w6
15 Feb 24
BIORA THERAPEUTICS / CLARKE NEUMANN ownership change
4:05pm